What is the initial setup for Omnipod 5 (automated insulin delivery system) with Humalog (insulin lispro) for a 66-year-old female patient with hyperglycemia (A1C of 10.8) and obesity (weight 182.6lb)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Omnipod 5 with Humalog Prescription for Severely Uncontrolled Diabetes

For a 66-year-old female weighing 182.6lb (82.8kg) with an A1C of 10.8%, the recommended initial Omnipod 5 setup with Humalog should include a total daily insulin dose of 24.8-41.4 units, with approximately 50% as basal and 50% as bolus insulin.

Initial Insulin Calculation

  • Calculate total daily dose (TDD) based on weight and degree of hyperglycemia:

    • For severely uncontrolled diabetes (A1C >10%), start with 0.3-0.5 units/kg/day 1
    • For this 82.8kg patient: 0.3 × 82.8 = 24.8 units (minimum) or 0.5 × 82.8 = 41.4 units (maximum) 1
  • Distribute insulin in basal-bolus pattern:

    • 50% as basal insulin: 12.4-20.7 units/day 1
    • 50% as prandial insulin: 12.4-20.7 units/day, divided between meals 1

Omnipod 5 Initial Settings

  • Basal Rate Programming:

    • Start with 50% of TDD as basal: 12.4-20.7 units/day 1
    • Program hourly basal rates (typically 0.5-0.9 units/hour) 1
    • Consider slightly higher basal rates overnight if dawn phenomenon is present 1
  • Bolus (Mealtime) Settings:

    • Initial insulin-to-carbohydrate ratio: 1 unit per 10-15g carbohydrate 1
    • Correction factor (insulin sensitivity): 1 unit to lower blood glucose by 30-50 mg/dL 1
    • Target blood glucose range: 80-130 mg/dL (fasting) and <180 mg/dL (post-meal) 1
  • Automated Mode Settings:

    • Enable automated insulin delivery mode after 24-48 hours of manual mode to establish baseline insulin needs 1
    • Set glucose target range: 110-130 mg/dL initially 1

Monitoring and Adjustment Protocol

  • Initial Follow-up:

    • Review glucose data after 3 days to assess patterns 1
    • Adjust basal rates, insulin-to-carbohydrate ratios, and correction factors based on glucose patterns 1
    • Schedule follow-up within 1-2 weeks for dose adjustments 1
  • Hypoglycemia Prevention:

    • Prescribe glucagon for emergency hypoglycemia 1
    • Set low glucose suspend threshold at 70 mg/dL 1
    • Consider reducing initial doses by 10-20% if patient has hypoglycemia unawareness or history of severe hypoglycemia 1

Special Considerations for Omnipod 5 with Humalog

  • Insulin Properties:

    • Humalog (insulin lispro) is a rapid-acting insulin analog with onset in 15-30 minutes and peak action in 30-90 minutes 2, 3
    • Humalog should be administered immediately before meals when using Omnipod 5 4
  • Pod Change Schedule:

    • Program pod changes every 72 hours 1
    • Include instructions for site rotation to prevent lipohypertrophy 1
  • Patient Education Requirements:

    • Provide comprehensive diabetes self-management education 1
    • Ensure patient understands carbohydrate counting, correction doses, and system alerts 1
    • Train on hypoglycemia recognition and management 1

Common Pitfalls and Caveats

  • Avoid Overbasalization:

    • Watch for clinical signals of excessive basal insulin: high bedtime-morning glucose differential, hypoglycemia, or high glucose variability 1
    • If basal dose exceeds 0.5 units/kg/day, reevaluate the regimen 1
  • Insulin Resistance Considerations:

    • With A1C of 10.8%, patient may have significant insulin resistance requiring higher doses 1, 5
    • Consider adding metformin if not contraindicated to improve insulin sensitivity 1
    • Monitor for need to increase insulin doses over time 1
  • Technology Adaptation:

    • Allow 2-4 weeks for algorithm adaptation and optimization 1
    • Ensure patient has backup insulin pens in case of pod failure 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.